William King Sells 53,433 Shares of Danaher Co. (DHR) Stock

Danaher Co. (NYSE:DHR) insider William King sold 53,433 shares of the business’s stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $101.64, for a total value of $5,430,930.12. Following the transaction, the insider now directly owns 36,425 shares of the company’s stock, valued at approximately $3,702,237. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Shares of DHR opened at $104.75 on Friday. Danaher Co. has a 12-month low of $91.65 and a 12-month high of $110.13. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.08 and a current ratio of 1.53. The stock has a market cap of $70.95 billion, a P/E ratio of 25.99, a PEG ratio of 1.95 and a beta of 1.04.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The firm had revenue of $4.85 billion for the quarter, compared to analyst estimates of $4.80 billion. During the same period in the previous year, the company posted $1.00 earnings per share. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. Analysts anticipate that Danaher Co. will post 4.51 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, October 26th. Investors of record on Friday, September 28th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $0.64 annualized dividend and a yield of 0.61%. Danaher’s dividend payout ratio is 15.88%.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. FMR LLC increased its stake in Danaher by 10.3% during the second quarter. FMR LLC now owns 21,011,026 shares of the conglomerate’s stock valued at $2,073,369,000 after acquiring an additional 1,963,116 shares during the period. Putnam Investments LLC increased its stake in Danaher by 0.8% during the second quarter. Putnam Investments LLC now owns 6,385,003 shares of the conglomerate’s stock valued at $630,072,000 after acquiring an additional 51,596 shares during the period. Flossbach Von Storch AG grew its stake in shares of Danaher by 3.2% in the 3rd quarter. Flossbach Von Storch AG now owns 5,729,830 shares of the conglomerate’s stock valued at $622,603,000 after purchasing an additional 180,025 shares during the period. Findlay Park Partners LLP grew its stake in shares of Danaher by 4.8% in the 2nd quarter. Findlay Park Partners LLP now owns 3,825,000 shares of the conglomerate’s stock valued at $377,451,000 after purchasing an additional 175,000 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in shares of Danaher by 14.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,426,709 shares of the conglomerate’s stock valued at $372,344,000 after purchasing an additional 424,317 shares during the period. Hedge funds and other institutional investors own 76.80% of the company’s stock.

DHR has been the subject of several research analyst reports. ValuEngine raised Danaher from a “hold” rating to a “buy” rating in a research report on Thursday, July 12th. Morgan Stanley boosted their price objective on Danaher from $113.00 to $120.00 and gave the stock an “overweight” rating in a research report on Friday, July 13th. Zacks Investment Research cut Danaher from a “hold” rating to a “sell” rating in a research report on Monday, July 16th. Bank of America set a $113.00 price objective on Danaher and gave the stock a “buy” rating in a research report on Thursday, July 19th. Finally, Royal Bank of Canada boosted their price objective on Danaher to $107.00 and gave the stock a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $112.14.

TRADEMARK VIOLATION WARNING: This article was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://sportsperspectives.com/2018/11/09/william-king-sells-53433-shares-of-danaher-co-dhr-stock.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Story: How is Preferred Stock Different from Common Stock?

Insider Buying and Selling by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply